
Samantha L. Shterengarts
Examiner (ID: 2, Phone: (571)270-5316 , Office: P/1626 )
| Most Active Art Unit | 1626 |
| Art Unit(s) | 4131, 1623, 1626 |
| Total Applications | 2313 |
| Issued Applications | 1786 |
| Pending Applications | 96 |
| Abandoned Applications | 469 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16476182
[patent_doc_number] => 10851110
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-12-01
[patent_title] => Heterocyclic inhibitors of PTPN11
[patent_app_type] => utility
[patent_app_number] => 16/270333
[patent_app_country] => US
[patent_app_date] => 2019-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 38333
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 390
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16270333
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/270333 | Heterocyclic inhibitors of PTPN11 | Feb 6, 2019 | Issued |
Array
(
[id] => 14438771
[patent_doc_number] => 20190177257
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-13
[patent_title] => THE OPTIMIZATION OF O-SULFONATED PHENOL PRODUCTION FOR CUMENE HYDROPEROXIDE CLEAVAGE
[patent_app_type] => utility
[patent_app_number] => 16/268042
[patent_app_country] => US
[patent_app_date] => 2019-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4710
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16268042
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/268042 | Optimization of O-sulfonated phenol production for cumene hydroperoxide cleavage | Feb 4, 2019 | Issued |
Array
(
[id] => 18910320
[patent_doc_number] => 11873289
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-01-16
[patent_title] => Pyrazole compounds and preparation thereof
[patent_app_type] => utility
[patent_app_number] => 16/966502
[patent_app_country] => US
[patent_app_date] => 2019-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6929
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16966502
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/966502 | Pyrazole compounds and preparation thereof | Jan 31, 2019 | Issued |
Array
(
[id] => 16822648
[patent_doc_number] => 20210137941
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-13
[patent_title] => CLOZAPINE FOR THE TREATMENT OF IG-E DRIVEN B CELL DISEASES
[patent_app_type] => utility
[patent_app_number] => 16/965269
[patent_app_country] => US
[patent_app_date] => 2019-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32334
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16965269
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/965269 | CLOZAPINE FOR THE TREATMENT OF IG-E DRIVEN B CELL DISEASES | Jan 30, 2019 | Abandoned |
Array
(
[id] => 14375067
[patent_doc_number] => 20190161446
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-30
[patent_title] => COMPOSITION FOR THE MODULATION OF THE ACTIVITY OF NON-STRUCTURE PROTEINS
[patent_app_type] => utility
[patent_app_number] => 16/261787
[patent_app_country] => US
[patent_app_date] => 2019-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5741
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16261787
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/261787 | Composition for the modulation of the activity of non-structure proteins | Jan 29, 2019 | Issued |
Array
(
[id] => 16762347
[patent_doc_number] => 20210107928
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-15
[patent_title] => SPHINGOSINE-1-PHOSPHATE ANALOG AND SYNTHESIS METHOD THEREFOR
[patent_app_type] => utility
[patent_app_number] => 16/965056
[patent_app_country] => US
[patent_app_date] => 2019-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9381
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16965056
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/965056 | SPHINGOSINE-1-PHOSPHATE ANALOG AND SYNTHESIS METHOD THEREFOR | Jan 27, 2019 | Abandoned |
Array
(
[id] => 16261160
[patent_doc_number] => 10752577
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-08-25
[patent_title] => Automated synthesis of small molecules using chiral, non-racemic boronates
[patent_app_type] => utility
[patent_app_number] => 16/255453
[patent_app_country] => US
[patent_app_date] => 2019-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 21
[patent_no_of_words] => 48300
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16255453
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/255453 | Automated synthesis of small molecules using chiral, non-racemic boronates | Jan 22, 2019 | Issued |
Array
(
[id] => 16655910
[patent_doc_number] => 20210052546
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-25
[patent_title] => METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF FGFR3-RELATED CHONDRODYSPLASIAS
[patent_app_type] => utility
[patent_app_number] => 16/964781
[patent_app_country] => US
[patent_app_date] => 2019-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6448
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16964781
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/964781 | Methods and pharmaceutical compositions for the treatment of FGFR3-related chondrodysplasias | Jan 22, 2019 | Issued |
Array
(
[id] => 16570570
[patent_doc_number] => 20210009576
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-14
[patent_title] => COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 16/963564
[patent_app_country] => US
[patent_app_date] => 2019-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37886
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16963564
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/963564 | Compounds | Jan 22, 2019 | Issued |
Array
(
[id] => 16657355
[patent_doc_number] => 20210053991
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-25
[patent_title] => BROMINATION OF PYRIDINE DERIVATIVES
[patent_app_type] => utility
[patent_app_number] => 16/960192
[patent_app_country] => US
[patent_app_date] => 2019-01-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7075
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16960192
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/960192 | Bromination of pyridine derivatives | Jan 13, 2019 | Issued |
Array
(
[id] => 14403521
[patent_doc_number] => 20190167604
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-06
[patent_title] => ARYLFLUOROSULFATE COMPOUNDS AND METHODS
[patent_app_type] => utility
[patent_app_number] => 16/243761
[patent_app_country] => US
[patent_app_date] => 2019-01-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7434
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16243761
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/243761 | ARYLFLUOROSULFATE COMPOUNDS AND METHODS | Jan 8, 2019 | Abandoned |
Array
(
[id] => 16492310
[patent_doc_number] => 10858334
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-12-08
[patent_title] => Method for aerobic oxidative coupling of thiophenes with a ligand-supported palladium catalyst
[patent_app_type] => utility
[patent_app_number] => 16/243394
[patent_app_country] => US
[patent_app_date] => 2019-01-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 15
[patent_no_of_words] => 13475
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16243394
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/243394 | Method for aerobic oxidative coupling of thiophenes with a ligand-supported palladium catalyst | Jan 8, 2019 | Issued |
Array
(
[id] => 17633841
[patent_doc_number] => 11344546
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-05-31
[patent_title] => Benzamide compounds
[patent_app_type] => utility
[patent_app_number] => 16/957862
[patent_app_country] => US
[patent_app_date] => 2019-01-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 7
[patent_no_of_words] => 42949
[patent_no_of_claims] => 109
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 394
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16957862
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/957862 | Benzamide compounds | Jan 7, 2019 | Issued |
Array
(
[id] => 16743232
[patent_doc_number] => 10968206
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-04-06
[patent_title] => Cannabinergic nitrate esters and related analogs
[patent_app_type] => utility
[patent_app_number] => 16/240190
[patent_app_country] => US
[patent_app_date] => 2019-01-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 34844
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16240190
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/240190 | Cannabinergic nitrate esters and related analogs | Jan 3, 2019 | Issued |
Array
(
[id] => 16885308
[patent_doc_number] => 20210171503
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-10
[patent_title] => GLYCOLATE OXIDASE INHIBITORS AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/958348
[patent_app_country] => US
[patent_app_date] => 2018-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31891
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16958348
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/958348 | GLYCOLATE OXIDASE INHIBITORS AND USE THEREOF | Dec 27, 2018 | Abandoned |
Array
(
[id] => 16276763
[patent_doc_number] => 10759777
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-09-01
[patent_title] => Carbazole-containing amides, carbamates, and ureas as cryptochrome modulators
[patent_app_type] => utility
[patent_app_number] => 16/233761
[patent_app_country] => US
[patent_app_date] => 2018-12-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 53
[patent_no_of_words] => 62876
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16233761
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/233761 | Carbazole-containing amides, carbamates, and ureas as cryptochrome modulators | Dec 26, 2018 | Issued |
Array
(
[id] => 16970397
[patent_doc_number] => 11066357
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-07-20
[patent_title] => Benzoannulene derivatives as antiviral agents
[patent_app_type] => utility
[patent_app_number] => 16/954464
[patent_app_country] => US
[patent_app_date] => 2018-12-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39703
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 361
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16954464
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/954464 | Benzoannulene derivatives as antiviral agents | Dec 23, 2018 | Issued |
Array
(
[id] => 15264555
[patent_doc_number] => 20190381011
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-19
[patent_title] => CARBOXAMIDE DERIVATIVES
[patent_app_type] => utility
[patent_app_number] => 16/230033
[patent_app_country] => US
[patent_app_date] => 2018-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32687
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 177
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16230033
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/230033 | CARBOXAMIDE DERIVATIVES | Dec 20, 2018 | Abandoned |
Array
(
[id] => 16398733
[patent_doc_number] => 20200339591
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-29
[patent_title] => COMPOSITIONS AND METHODS OF TREATMENT FOR NEUROLOGICAL DISORDERS COMPRISING A DEMENTIA
[patent_app_type] => utility
[patent_app_number] => 16/955811
[patent_app_country] => US
[patent_app_date] => 2018-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17512
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16955811
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/955811 | COMPOSITIONS AND METHODS OF TREATMENT FOR NEUROLOGICAL DISORDERS COMPRISING A DEMENTIA | Dec 19, 2018 | Abandoned |
Array
(
[id] => 17815360
[patent_doc_number] => 11420958
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-08-23
[patent_title] => Aryl and heteroaryl substituted indole compounds
[patent_app_type] => utility
[patent_app_number] => 16/955314
[patent_app_country] => US
[patent_app_date] => 2018-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19198
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 295
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16955314
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/955314 | Aryl and heteroaryl substituted indole compounds | Dec 18, 2018 | Issued |